2018.08.11
VitaFlow® Has Been Admitted into the “Green Path”
Shanghai, China - VitaFlow® Transcatheter Aortic Valve and Delivery System ("VitaFlow®"), in-house developed by MicroPort CardioFlow has been admitted into the "Green Path" by the China Food and Drug Administration ("CFDA"), a special fast-track procedure for innovative medical devices to gain CFDA approval.
Read More







沪公网安备 31011502014876号
are registered trademarks of MicroPort CardioFlow Medtech Corporation.